Six biotechs merge to take on Bridge­Bio, Abeona in 'but­ter­fly skin' dis­ease, with eyes al­so set on Duchenne

A rel­a­tive­ly un­known clin­i­cal-stage biotech, with a med­ical chief who’s been in­volved in mul­ti­ple Bridge­Bio ven­tures, has raised a small fi­nanc­ing round and ap­pears to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER